APA (7th ed.) Citation

Güren, A. K., Majidova, N., Çakır, İ., Sever, N., Kocaaslan, E., Erel, P., . . . Köstek, O. Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients. Shiraz University of Medical Sciences.

Chicago Style (17th ed.) Citation

Güren, Ali Kaan, et al. Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients. Shiraz University of Medical Sciences.

MLA (9th ed.) Citation

Güren, Ali Kaan, et al. Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients. Shiraz University of Medical Sciences.